Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
TNGX Tango Therapeutics
- 3.100
- +0.160+5.44%
Close Dec 20 16:00 ET
- 3.000
- -0.100-3.23%
Post 20:01 ET
333.00MMarket Cap-2.70P/E (TTM)
3.130High2.800Low2.82MVolume2.910Open2.940Pre Close8.69MTurnover5.63%Turnover RatioLossP/E (Static)107.42MShares13.00552wk High1.45P/B155.09MFloat Cap2.70052wk Low--Dividend TTM50.03MShs Float18.840Historical High--Div YieldTTM11.22%Amplitude2.470Historical Low3.084Avg Price1Lot Size
About Tango Therapeutics Company
Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need. The company was founded by Alan Ashworth, William G. Kaelin, Jr., Jose Baselga, and Antoni Ribas in 2017 and is headquartered in Boston, MA.
Company Profile
SymbolTNGX
Company NameTango Therapeutics
Listing DateSep 3, 2020
Issue Price10.00
Founded2017
CEODr. Barbara L. Weber, M.D.
MarketNASDAQ
Employees140
Fiscal Year Ends12-31
Address201 Brookline Avenue,Suite 901
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02215
Phone1-857-320-4900
Websitehttp://www.tangotx.com
Company Executives
- Name
- Position
- Salary
- Dr. Barbara L. Weber, M.D.
- President, Chief Executive Officer and Director
- 3.39M
- Douglas Barry
- General Counsel, Chief Compliance Officer and Corporate Secretary
- --
- Julie Carretero
- Chief Human Resources Officer
- --
- Daniella Beckman
- Chief Financial Officer
- 1.52M
- Alexis A. Borisy, A.M.
- Chairman of the Board
- 171.53K
- Dr. Adam Crystal, M.D.,PhD
- President, Research and Development
- 3.11M
- Dr. Malte Peters, M.D.
- Independent Director
- 139.03K
- Dr. Mace Rothenberg, M.D.
- Independent Director
- 141.53K
- Lesley Ann Calhoun
- Independent Director
- 148.03K
- Kanishka Pothula
- Independent Director
- --
- John B. Ketchum
- Independent Director
- 375.87K